News
ICViewExpert PerspectivesMedical World NewsVideosWebinars
Conference
Infection Control TodaySupplements And Featured Publications
CME/CEJob BoardPartnersSponsoredWhitepapers
Print SubscriptioneNewsletter
Educator of the Year Nomination FormEducator of the Year Official RulesEducator of the Year
Advanced Technology
Bug of the Month
COVID-19
Environmental Services
HAIs
Hand Hygiene
Long-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Prevention
Sterile Processing
Surface Disinfection
Vascular Access
Spotlight -
  • Expert Perspectives on Personal Protection Guidelines and Standardization Practices
  • Bug of the Month
Advanced Technology
Bug of the Month
COVID-19
Environmental Services
HAIs
Hand Hygiene
Long-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Prevention
Sterile Processing
Surface Disinfection
Vascular Access
    • News
    • Conference
Advertisement

One-Third of U.S. Children Have Not Received All Recommended Childhood Vaccines, Study Finds

Nov 18, 2015
Article

Approximately 34 percent of children in the United States do not receive all doses of vaccines recommended by the Advisory Committee on Immunization Practices (ACIP) by age 2, according to a new study by researchers at RTI Health Solutions, a business unit of RTI International.

This is consistent with findings reported by the Centers for Disease Control and Prevention. The ACIP recommends most children receive a series of routine immunizations, consisting of 19 doses of vaccines administered at age-specific intervals between birth and age 2 to protect against 11 diseases.

The study, published in press in Vaccine, used data from the 2012 National Immunization Survey, an annual survey conducted by the CDC, to examine vaccination coverage among a nationally representative sample of nearly 12,000 2-year-olds in the United States. Researchers estimated the proportion of children who completed the ACIP recommended number of doses by 8, 18 and 24 months of age (completion rates); and whether each dose was administered at age-appropriate times between birth and 24 months (compliance rates).

"Although completion rates of many individual vaccines, such as the poliovirus vaccine, were near the national Healthy People 2020 targets, one-third of children did not complete all vaccines recommended by the ACIP," said Samantha Kurosky, an associate director in the Health Economics group at RTI Health Solutions and lead author of the study. "This means a portion of children are protected against some diseases, yet are partially or not at all immunized against others by the time they turn 2 years old."

Researchers also estimated approximately 77 percent of children were non-compliant with the ACIP schedule, receiving one or more of the 19 recommended doses outside of its respective age-appropriate window, or never receiving the dose at all by 24 months of age. Further, 43 percent of the sample was non-compliant with one or more doses in the recommended schedule for a total of 7 months or more, between birth and 24 months of age.

"Our research indicates that a child's immunization status is dynamic between birth and age 2," Kurosky says. "There are periods of time when a child is behind according to the ACIP schedule, but may eventually catch up by the time they turn 24 months. The recommended age-windows for each dose of vaccine are developed to not only maximize the effectiveness of the body's response to the vaccine, but to reduce disease susceptibility at a time when children are at a very high risk for complications if infected with these diseases."

Western states had the lowest rates of completion and compliance. Southern states had the highest completion rates, yet compliance rates were moderate, indicating that children were receiving vaccines late, but catching up by age 2. The most undervaccinated state was Alaska where 55 percent of children completed all recommended doses by age 2; whereas, Mississippi had the highest completion rate at 77 percent.

"The regional patterns we observed point to a need for continued localized, evidence-based interventions that address barriers to vaccination at the family, provider, institutional and policy levels," Kurosky says. "By understanding each community's specific needs, we have a better chance of providing the right tools that can lead to improved vaccination rates across the nation."

The study was sponsored and co-authored by GlaxoSmithKline.

Reference: "Completion and Compliance of Childhood Vaccinations in the United States" by Samantha Kurosky, Keith Davis and Girishanthy Krishnarajah. (DOI: 10.1016/j.vaccine.2015.11.011), In Press, Vaccine, published by Elsevier.

Source: RTI International

Related Videos
Medical investigators going over data. (AdobeStock 589197902 by Wasan)
CDC logo is seen on a laptop. (Adobe Stock 428450603 by monticellllo)
Association for the Health Care Environment (Logo used with permission)
Ambassador Deborah Birx, , speaks with Infection Control Today about masks in schools and the newest variant.
mRNA technology  (Adobe Stock 485886181 by kaptn)
Ambassador Deborah Birx, MD
Woman lying in hospital bed (Adobe Stock, unknown)
Photo of a model operating room. (Photo courtesy of Indigo-Clean and Kenall Manufacturing)
GIANTmicrobes at the 2023 APIC Annual Conference and Exhibition.  (Photo by the author)
Related Content

Weekly Rounds: Data-Driven Action Against COVID-19, Emerging Pathogens, HIV Vaccine Trials Begin, and More

September 22nd 2023

NIH Announces HIV Vaccine Clinical Trial Begins

September 20th 2023

Organized Disinformation Fanning the COVID-19 Flames of Vaccine Hesitancy  

September 18th 2023

Hot Topics in IPC: COVID-19 Updated Booster, Legionella Infections, and Hospital Leadership

September 18th 2023

Protecting HCWs: Plague Doctor's Masks to the Personal Protective Equipment of Tomorrow

September 15th 2023

AHE Exchange Conference & Solution Center 2023 Review

September 14th 2023

Weekly Rounds: Data-Driven Action Against COVID-19, Emerging Pathogens, HIV Vaccine Trials Begin, and More

September 22nd 2023

NIH Announces HIV Vaccine Clinical Trial Begins

September 20th 2023

Organized Disinformation Fanning the COVID-19 Flames of Vaccine Hesitancy  

September 18th 2023

Hot Topics in IPC: COVID-19 Updated Booster, Legionella Infections, and Hospital Leadership

September 18th 2023

Protecting HCWs: Plague Doctor's Masks to the Personal Protective Equipment of Tomorrow

September 15th 2023

AHE Exchange Conference & Solution Center 2023 Review

September 14th 2023

Weekly Rounds: Data-Driven Action Against COVID-19, Emerging Pathogens, HIV Vaccine Trials Begin, and More

September 22nd 2023

NIH Announces HIV Vaccine Clinical Trial Begins

September 20th 2023

Organized Disinformation Fanning the COVID-19 Flames of Vaccine Hesitancy  

September 18th 2023

Hot Topics in IPC: COVID-19 Updated Booster, Legionella Infections, and Hospital Leadership

September 18th 2023

Protecting HCWs: Plague Doctor's Masks to the Personal Protective Equipment of Tomorrow

September 15th 2023

AHE Exchange Conference & Solution Center 2023 Review

September 14th 2023
Related Content
Advertisement

weekly rounds with infection control today

Weekly Rounds: Data-Driven Action Against COVID-19, Emerging Pathogens, HIV Vaccine Trials Begin, and More

September 22nd 2023
Article

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending September 24, 2023.


NIH Announces HIV Vaccine Clinical Trial Begins

NIH Announces HIV Vaccine Clinical Trial Begins

September 20th 2023
Article

A new preventative vaccine has been developed incorporating technology funded by the NIH since 2004. The trials will be conducted in the United States and South Africa.


Vial of COVID-19 vaccine, bottle for injection with syringe.  (Adobe Stock 331786954 by myskin)

Organized Disinformation Fanning the COVID-19 Flames of Vaccine Hesitancy  

September 18th 2023
Article

Randomized controlled trials show masks are effective. With COVID-19, even one mistake in protective gear usage could lead to infection and obscure results.


In this Hot Topics in IPC, Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC, discusses COVID-19 vaccines and boosters, Legionella infections from transplants, and hospital leadership.

Hot Topics in IPC: COVID-19 Updated Booster, Legionella Infections, and Hospital Leadership

September 18th 2023
Article

In this Hot Topics in IPC, Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC, discusses COVID-19 vaccines and boosters, Legionella infections from transplants, and hospital leadership.


Plague doctor, a physician who treated bubonic plague.  (Adobe Stock FILE #: 559266031 by Worldillustrator)

Protecting HCWs: Plague Doctor's Masks to the Personal Protective Equipment of Tomorrow

September 15th 2023
Article

Plague doctors' historical attire was an early form of PPE. While modern PPE has improved, the quest for better, more comfortable protection continues as we aim for a future where health care workers can provide care confidently.


AHE: Association for the Health Care Environment  (Photo used with permission by AHE)

AHE Exchange Conference & Solution Center 2023 Review

September 14th 2023
Article

Health care environmental professionals met in Dallas, Texas, from July 31 to August 2, 2023, at the AHE Exchange Conference & Solution Center. Infection Control Today® asked Rock Jensen, AHE advisory board chair and administrative director of support services for Yuma Regional Medical Center in Arizona, about AHE’s areas of emphasis for leadership in environmental services (EVS).

Advertise
About Us
Editorial Board
Contact Us
Job Board
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News